CDX2 and gastric cancer: Several studies have reported that patients with low expression levels of CDX2 in intestinal metaplasia and dysplasia are more likely to progress into GC, and GC patients who were positive for CDX2 expression showed a higher survival rate than those who were CDX2 negative.